These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine. Calcagno A; Coppola N; Sarmati L; Tadolini M; Parrella R; Matteelli A; Riccardi N; Trezzi M; Di Biagio A; Pirriatore V; Russo A; Gualano G; Pontali E; Surace L; Falbo E; Mencarini J; Palmieri F; Gori A; Schiuma M; Lapadula G; Goletti D; Infection; 2024 Jun; 52(3):737-765. PubMed ID: 38329686 [TBL] [Abstract][Full Text] [Related]
3. What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? Sharma SK; Upadhyay V; Mohan A Indian J Med Res; 2021 Mar; 154(3):405-409. PubMed ID: 35345066 [No Abstract] [Full Text] [Related]
4. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. Pennington KM; Vu A; Challener D; Rivera CG; Shweta FNU; Zeuli JD; Temesgen Z J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100244. PubMed ID: 34036184 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Clin Infect Dis; 2020 Aug; 71(4):905-913. PubMed ID: 32797222 [TBL] [Abstract][Full Text] [Related]
6. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32636299 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Clin Infect Dis; 2020 Aug; 71(4):e1-e36. PubMed ID: 32628747 [TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Koh WJ; Kwon OJ; Lee KS Korean J Radiol; 2002; 3(3):145-57. PubMed ID: 12271159 [TBL] [Abstract][Full Text] [Related]
10. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Subcommittee OT Thorax; 2000 Mar; 55(3):210-8. PubMed ID: 10679540 [No Abstract] [Full Text] [Related]
11. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society. Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763 [TBL] [Abstract][Full Text] [Related]
15. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978 [TBL] [Abstract][Full Text] [Related]
16. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226 [TBL] [Abstract][Full Text] [Related]
17. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
18. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [TBL] [Abstract][Full Text] [Related]